Works matching DE "FLUVOXAMINE"

Results: 159

Outpatients prescribed with fluvoxamine around the time of COVID-19 diagnosis are not at a reduced risk of subsequent hospitalization and death compared to their non-prescribed peers: population-based matched cohort study.

Published in:

European Journal of Clinical Pharmacology, 2023, v. 79, n. 5, p. 643, doi. 10.1007/s00228-023-03479-3

By:

Trkulja, Vladimir;
Kodvanj, Ivan

Publication type:

Article

Why we should not recommend or offer fluvoxamine to COVID-19 patients?

Published in:

2023

By:

Trkulja, Vladimir

Publication type:

Letter to the Editor

Obsessive-Compulsive Disorder during the COVID-19 Pandemic.

Published in:

2023

By:

Fiaschè, Federica;
Kotzalidis, Georgios D.;
Alcibiade, Alessandro;
Del Casale, Antonio

Publication type:

Editorial

Are there Neuropsychological Predictors for Response and Nonresponse in First-Episode Drug Naïve Patients with OCD? A 12 Weeks Interventional Study.

Published in:

Annals of Indian Psychiatry, 2023, v. 7, n. 4, p. 303, doi. 10.4103/aip.aip_110_22

By:

Brar, Jasmine;
Sidana, Ajeet;
Chauhan, Nidhi;
Bajaj, Manoj;
Jaswal, Sumeesha

Publication type:

Article

Fluvoxamine for the Early Treatment of SARS-CoV-2 Infection: A Review of Current Evidence.

Published in:

Drugs, 2021, v. 81, n. 18, p. 2081, doi. 10.1007/s40265-021-01636-5

By:

Facente, Shelley N.;
Reiersen, Angela M.;
Lenze, Eric J.;
Boulware, David R.;
Klausner, Jeffrey D.

Publication type:

Article

In Vitro Evaluation of CYP‐Mediated Metabolism of Fezolinetant and Pharmacokinetic Interaction Between Fezolinetant and Fluvoxamine in Healthy Postmenopausal Smokers and Nonsmokers.

Published in:

Journal of Clinical Pharmacology, 2025, v. 65, n. 4, p. 508, doi. 10.1002/jcph.6157

By:

Iwai, Megumi;
Nielsen, Jace;
Miyagawa, Mayuko;
Patton, Melanie;
Bonate, Peter L.;
Wang, Xuegong;
Wojtkowski, Tomasz;
Sinn, Angela;
Huang, Jiayin

Publication type:

Article

Drug‐Drug Interaction Study to Assess the Effect of Cytochrome P450 Inhibition and Induction on the Pharmacokinetics of the Novel Cereblon Modulator Avadomide (CC‐122) in Healthy Adult Subjects.

Published in:

Journal of Clinical Pharmacology, 2019, v. 59, n. 12, p. 1620, doi. 10.1002/jcph.1453

By:

Ogasawara, Ken;
MacGorman, Kimberly;
Liu, Liangang;
Chen, Jian;
Carayannopoulos, Leonidas N.;
Zhou, Simon;
Palmisano, Maria;
Li, Yan

Publication type:

Article

The effects of most commonly prescribed second generation antidepressants on driving ability: a systematic review.

Published in:

Journal of Neural Transmission, 2013, v. 120, n. 1, p. 225, doi. 10.1007/s00702-012-0833-8

By:

Brunnauer, Alexander;
Laux, Gerd

Publication type:

Article

Fluvoxamine by itself has potential to directly induce long QT syndrome at supra-therapeutic concentrations.

Published in:

Journal of Toxicological Sciences, 2015, v. 40, n. 1, p. 33, doi. 10.2131/jts.40.33

By:

Yukiko Yamazaki-Hashimoto;
Yuji Nakamura;
Hiroshi Ohara;
Xin Cao;
Ken Kitahara;
Hiroko Izumi-Nakaseko;
Kentaro Ando;
Hiroshi Yamazaki;
Takanori Ikeda;
Junichi Yamazaki;
Atsushi Sugiyama

Publication type:

Article

Spermcasting of spermatozeugmata by the bivalves N utricola confusa and N . tantilla.

Published in:

Invertebrate Biology, 2011, v. 130, n. 4, p. 334, doi. 10.1111/j.1744-7410.2011.00245.x

By:

Falese, Lillian E.;
Russell, Michael P.;
Dollahon, Norman R.

Publication type:

Article

A Narrative Review: Serotonin Reuptake Inhibitors and the Risk of Suicidal Ideation in Adolescents.

Published in:

Adolescents (2673-7051), 2025, v. 5, n. 1, p. 5, doi. 10.3390/adolescents5010005

By:

Gage, Dylan S.;
Priefer, Veronica E.;
Priefer, Ronny

Publication type:

Article

Evaluation of Oxidant-Antioxidant Status of Fluvoxamine on Human Lymphocyte Cell Culture.

Published in:

Hittite Journal of Science & Engineering, 2021, v. 8, n. 1, p. 79, doi. 10.17350/HJSE19030000216

By:

Severcan, Suzan Muratoglu;
Severcan, Cinar;
Tazehkand, Mostafa Norizadeh;
Oz, Zehra Safi;
Gurbuz, Aslihan

Publication type:

Article

A Report of Rabbit Syndrome Who Benefited from Sigma 1 Agonist Fluvoxamine.

Published in:

2019

By:

Albayrak, Yakup;
Beyazyüz, Murat;
Abbak, Özlem;
Altındağ, Ece

Publication type:

Case Study

Pharmacological Management of Central Post-Stroke Pain: A Practical Guide.

Published in:

CNS Drugs, 2014, v. 28, n. 9, p. 787, doi. 10.1007/s40263-014-0194-y

By:

Kim, Jong

Publication type:

Article

Evaluation of oral antidepressant drugs for adaptation to the simple suspension method.

Published in:

Journal of Young Pharmacists, 2014, v. 6, n. 4, p. 56, doi. 10.5530/jyp.2014.4.10

By:

Hiroyuki Hichiya;
Yusuke Mimura;
Nobumitsu Hanioka

Publication type:

Article

Psychopharmacological Options for Treating Impulsivity.

Published in:

Psychiatric Times, 2015, v. 32, n. 8, p. 58

By:

Grant, Jon E.;
Chamberlain, Samuel R.

Publication type:

Article

Benzodiazepines as a Monotherapy in Depressive Disorders: A Systematic Review.

Published in:

2018

By:

Benasi, Giada;
Guidi, Jenny;
Offidani, Emanuela;
Balon, Richard;
Rickels, Karl;
Fava, Giovanni A.

Publication type:

journal article

Cognitive Therapy versus Fluvoxamine as a Second-Step Treatment in Obsessive-Compulsive Disorder Nonresponsive to First-Step Behavior Therapy.

Published in:

Psychotherapy & Psychosomatics, 2012, v. 81, n. 6, p. 366, doi. 10.1159/000339369

By:

van Balkom, Anton J.L.M.;
Emmelkamp, Paul M.G.;
Eikelenboom, Merijn;
Hoogendoorn, Adriaan W.;
Smit, Johannes H.;
van Oppen, Patricia

Publication type:

Article

Sudden Gains in the Treatment of Obsessive-Compulsive Disorder.

Published in:

Psychotherapy & Psychosomatics, 2011, v. 81, n. 1, p. 44, doi. 10.1159/000329995

By:

Aderka, Idan M.;
Anholt, Gideon E.;
van Balkom, Anton J.L.M.;
Smit, Johannes H.;
Hermesh, Haggai;
van Oppen, Patricia

Publication type:

Article

Transdermal clonidine for mitigating posttraumatic stress disorder in an adolescent.

Published in:

American Journal of Health-System Pharmacy, 2019, v. 76, n. 8, p. 487, doi. 10.1093/ajhp/zxz021

By:

Ye, Lu;
Shipley, Erik;
Lippmann, Steven

Publication type:

Article

Regulator of G-protein signaling 6 (RGS6) promotes anxiety and depression by attenuating serotonin-mediated activation of the 5-HT<sub>1A</sub> receptor-adenylyl cyclase axis.

Published in:

FASEB Journal, 2014, v. 28, n. 4, p. 1735, doi. 10.1096/fj.13-235648

By:

Stewart, Adele;
Maity, Biswanath;
Wunsch, Amanda M.;
Meng, Fantao;
Qi Wu;
Wemmie, John A.;
Fisher, Rory A.

Publication type:

Article

Ivermectin and the TOGETHER Trial.

Published in:

Regulation, 2022, v. 45, n. 2, p. 2

By:

HOOPER, CHARLES L.;
HENDERSON, DAVID R.

Publication type:

Article

Homozygosity for rs17775810 Minor Allele Associated With Reduced Mortality of COVID-19 in the UK Biobank Cohort.

Published in:

In Vivo, 2021, v. 35, n. 2, p. 965, doi. 10.21873/invivo.12338

By:

LEHRER, STEVEN;
RHEINSTEIN, PETER H.

Publication type:

Article

Selective serotonin reuptake inhibitors and perioperative bleeding in endoscopic dacryocystorhinostomy.

Published in:

Eye (0950-222X), 2014, v. 28, n. 10, p. 1268, doi. 10.1038/eye.2014.152

By:

Saad, J;
Ziahosseini, K;
Wearne, G;
Ali, S;
Malhotra, R

Publication type:

Article

Effects of BD1047, a σ<sub>1</sub> receptor antagonist, on the expression of mTOR, Camk2γ and GSK-3β in fluvoxamine-treated N2a cells.

Published in:

Experimental & Therapeutic Medicine, 2014, v. 7, n. 2, p. 435, doi. 10.3892/etm.2013.1438

By:

DONG-AN SU;
RI-YUE JIANG;
NING LIU;
LIANG-CAI DING;
DA-MING WANG;
HAI-YING YU;
EN-SHI YAN;
MEI-HUA ZHU;
BIN ZHU

Publication type:

Article

Involvement of GABA receptors in 5-HT and σ receptor synergism on prefrontal dopaminergic transmission under circulating neurosteroid deficiency.

Published in:

Psychopharmacology, 2016, v. 233, n. 17, p. 3125, doi. 10.1007/s00213-016-4353-3

By:

Ago, Yukio;
Hasebe, Shigeru;
Hiramatsu, Naoki;
Mori, Kazuya;
Watabe, Yuji;
Onaka, Yusuke;
Hashimoto, Hitoshi;
Takuma, Kazuhiro;
Matsuda, Toshio

Publication type:

Article

The clinical potentials of adjunctive fluvoxamine to clozapine treatment: a systematic review.

Published in:

Psychopharmacology, 2016, v. 233, n. 5, p. 741, doi. 10.1007/s00213-015-4161-1

By:

Polcwiartek, Christoffer;
Nielsen, Jimmi

Publication type:

Article

Optimising treatment of schizophrenia: the role of adjunctive fluvoxamine.

Published in:

2016

By:

Gee, Siobhan;
Howes, Oliver

Publication type:

Editorial

Histamine H receptor occupancy by the new-generation antidepressants fluvoxamine and mirtazapine: a positron emission tomography study in healthy volunteers.

Published in:

Psychopharmacology, 2013, v. 230, n. 2, p. 227, doi. 10.1007/s00213-013-3146-1

By:

Sato, Hirotoshi;
Ito, Chihiro;
Tashiro, Manabu;
Hiraoka, Kotaro;
Shibuya, Katsuhiko;
Funaki, Yoshihito;
Iwata, Ren;
Matsuoka, Hiroo;
Yanai, Kazuhiko

Publication type:

Article

Seizures during antidepressant treatment in psychiatric inpatients-results from the transnational pharmacovigilance project 'Arzneimittelsicherheit in der Psychiatrie' (AMSP) 1993-2008.

Published in:

Psychopharmacology, 2013, v. 230, n. 2, p. 191, doi. 10.1007/s00213-013-3281-8

By:

Köster, M.;
Grohmann, R.;
Engel, R.;
Nitsche, M.;
Rüther, E.;
Degner, D.

Publication type:

Article

Serotonin Syndrome Due to Overdose Intake of SSRI.

Published in:

2015

By:

Orak, Yavuz;
Akbulut, Sevgi

Publication type:

Case Study

Chest pain following the use of fluvoxamine in depression.

Published in:

Proceedings of Singapore Healthcare, 2019, v. 28, n. 2, p. 138, doi. 10.1177/2010105818802993

By:

Pang, Tamara;
Gudi, Alakananda

Publication type:

Article

Novel ensemble method for the prediction of response to fluvoxamine treatment of obsessive–compulsive disorder.

Published in:

Neuropsychiatric Disease & Treatment, 2018, v. 14, p. 2027, doi. 10.2147/NDT.S173388

By:

Hasanpour, Hesam;
Meibodi, Ramak Ghavamizadeh;
Navi, Keivan;
Asadi, Sareh

Publication type:

Article

Association of serotonin receptor 2a haplotypes with obsessive–compulsive disorder and its treatment response in Iranian patients: a genetic and pharmacogenetic study.

Published in:

Neuropsychiatric Disease & Treatment, 2018, v. 14, p. 1199, doi. 10.2147/NDT.S163946

By:

Sina, Marzie;
Ahmadiani, Abolhassan;
Asadi, Sareh;
Shams, Jamal

Publication type:

Article

Post-marketing observational program of the effectiveness of fluvoxamine for the treatment of depression in patients with neurological disorders: the FRIENDS study.

Published in:

Neuropsychiatric Disease & Treatment, 2017, v. 13, p. 2747, doi. 10.2147/NDT.S145614

By:

Yahno, Nikolay N.;
Fedotova, Anastasia V.

Publication type:

Article

An observational study of duloxetine versus SSRI monotherapy for the treatment of painful physical symptoms in Japanese patients with major depressive disorder: primary analysis.

Published in:

Neuropsychiatric Disease & Treatment, 2017, v. 13, p. 2105, doi. 10.2147/NDT.S131438

By:

Atsushi Kuga;
Toshinaga Tsuji;
Shinji Hayashi;
Mako Matsubara;
Shinji Fujikoshi;
Hirofumi Tokuoka;
Aki Yoshikawa;
Rodrigo Escobar;
Kazuhide Tanaka;
Takaharu Azekawa

Publication type:

Article

Influence of fluvoxamine on plasma interleukin-6 or clinical improvement in patients with major depressive disorder.

Published in:

Neuropsychiatric Disease & Treatment, 2017, v. 13, p. 437, doi. 10.2147/NDT.S123121

By:

Reiji Yoshimura;
Asuka Katsuki;
Kiyokazu Atake;
Hikaru Hori;
Ryohei Igata;
Yuki Konishi

Publication type:

Article

Tiagabine augmentation to fluvoxamine-risperidone combination in the treatment of obsessive-compulsive disorder.

Published in:

World Journal of Biological Psychiatry, 2009, v. 10, n. 4_3, p. 953, doi. 10.1080/15622970701739526

By:

Oulis, Panagiotis;
Masdrakis, Vasilios G.;
Karapoulios, Evangelos;
Karakatsanis, Nikolaos A.;
Kouzoupis, Anastasios V.;
Konstantakopoulos, George;
Soldatos, Constantin R.

Publication type:

Article

A case with occurring adverse effects when cross-over titration from fluvoxamine to paroxetine associated with increasing the plasma fluvoxamine level in major depressive disorder.

Published in:

World Journal of Biological Psychiatry, 2009, v. 10, n. 4_2, p. 620, doi. 10.1080/15622970802118349

By:

Hori, Hikaru;
Yoshimura, Reiji;
Ueda, Nobuhisa;
Ikenouchi-Sugita, Atsuko;
Umene-Nakano, Wakako;
Nakamura, Jun

Publication type:

Article

Fluvoxamine alters the activity of energy metabolism enzymes in the brain.

Published in:

Brazilian Journal of Psychiatry / Revista Brasileira de Psiquiatria, 2014, v. 36, n. 3, p. 220, doi. 10.1590/1516-4446-2013-1202

By:

Ferreira, Gabriela K.;
Cardoso, Mariane R.;
Jeremias, Isabela C.;
Gonçalves, Cinara L.;
Freitas, Karolina V.;
Antonini, Rafaela;
Scaini, Giselli;
Rezin, Gislaine T.;
Quevedo, João;
Streck, Emilio L.

Publication type:

Article

Effects of fluvoxamine on nerve growth factor-induced neurite outgrowth inhibition by dexamethasone in PC12 cells.

Published in:

Bioscience, Biotechnology & Biochemistry, 2019, v. 83, n. 4, p. 659, doi. 10.1080/09168451.2018.1553607

By:

Matsushima, Yukari;
Terada, Kazuki;
Takata, Jiro;
Karube, Yoshiharu;
Kamei, Chiaki;
Sugimoto, Yumi

Publication type:

Article

Application of tandem dispersive liquid-liquid microextraction for the determination of doxepin, citalopram, and fluvoxamine in complicated samples.

Published in:

Journal of Separation Science, 2016, v. 39, n. 24, p. 4828, doi. 10.1002/jssc.201600673

By:

Fahimirad, Bahareh;
Asghari, Alireza;
Bazregar, Mohammad;
Rajabi, Maryam;
Fahimi, Ebrahim

Publication type:

Article

A drug-drug interaction study to assess the effect of the CYP1A2 inhibitor fluvoxamine on the pharmacokinetics of dovitinib (TKI258) in patients with advanced solid tumors.

Published in:

2018

By:

de Weger, Vincent A.;
Goel, Sanjay;
von Moos, Roger;
Schellens, Jan H. M.;
Mach, Nicholas;
Tan, Eugene;
Anand, Suraj;
Scott, Jeffrey W.;
Lassen, Ulrik

Publication type:

journal article

Anticompulsive Activity of a New Pyrazolo[C]Pyridine Derivative GIZh-72 under Conditions of Unpredictable Chronic Mild Stress.

Published in:

Bulletin of Experimental Biology & Medicine, 2016, v. 161, n. 3, p. 377, doi. 10.1007/s10517-016-3418-y

By:

Kudryashov, N.;
Kalinina, T.;
Zhmurenko, L.;
Voronina, T.

Publication type:

Article

Signaling mechanisms involved in the acute effects of estradiol on 5-HT clearance.

Published in:

International Journal of Neuropsychopharmacology, 2014, v. 17, n. 5, p. 765, doi. 10.1017/S146114571300165X

By:

Benmansour, Saloua;
Privratsky, Anthony A.;
Adeniji, Opeyemi S.;
Frazer, Alan

Publication type:

Article

A Simple Liquid Chromatographic Method for the Simultaneous Determination of Antidepressants in Pharmaceutical Preparations.

Published in:

Journal of the Chinese Chemical Society, 2012, v. 59, n. 9, p. 1125, doi. 10.1002/jccs.201100576

By:

Pan, Chi-Wen;
Duh, Tsai-Hui;
Wu, Hsin-Lung

Publication type:

Article

Adverse effects of long-term administration of fluvoxamine on haematology, blood biochemistry and fertility in male albino rats: a possible effect of cessation.

Published in:

Andrologia, 2016, v. 48, n. 9, p. 914, doi. 10.1111/and.12532

By:

Galal, A. A. A.;
Alam, R. T. M.;
Abd El‐Aziz, R. M.

Publication type:

Article

Combination thrapy of hydroalcoholic extract of Pistacia atlantica kurdica and fluvoxamine on spatial memory of immobilization rat.

Published in:

Journal of Gorgan University of Medical Sciences, 2017, v. 19, n. 3, p. 31

By:

Mohammadzadeh, M;
Babaeifar, F;
Babaei, F

Publication type:

Article

Obsessive-compulsive (Anankastic) Personality Disorder: A Poorly Researched Landscape with Significant Clinical Relevance.

Published in:

2016

By:

Reddy, M. S.;
Starlin Vijay, M.;
Reddy, Swetha

Publication type:

Editorial

Fluvoxamine Plays an Integral Role in the Alteration of Sexual Behavioral Pattern more in Females than Males.

Published in:

2012

By:

Santra, Ranjita

Publication type:

Letter